Drugs / VYN201
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06493578 Comparator | Jun 2024 → Jul 2025 | vitiligo | Vyne Therapeutics Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VYN201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06493578 ↗ |
| Route | Topical | “VYN201 Gel is a topical formulation applied as a thin layer to affected areas.” NCT06493578 ↗ |